Pigmented Hypertrichosis with Insulin-Dependent Diabetes Mellitus Syndrome: A Case Series
Language English Country Switzerland Media print-electronic
Document type Case Reports, Journal Article
PubMed
38163427
DOI
10.1159/000536019
PII: 000536019
Knihovny.cz E-resources
- Keywords
- Autoantibodies, Diabetes, H syndrome, PHID syndrome, SLC29A3,
- MeSH
- Autoantibodies blood MeSH
- Diabetes Mellitus, Type 1 * genetics pathology complications MeSH
- Child MeSH
- Hypertrichosis * genetics pathology complications MeSH
- Humans MeSH
- Adolescent MeSH
- Mutation MeSH
- Consanguinity MeSH
- Child, Preschool MeSH
- Nucleoside Transport Proteins * genetics MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Autoantibodies MeSH
- Nucleoside Transport Proteins * MeSH
- SLC29A3 protein, human MeSH Browser
INTRODUCTION: Pigmented hypertrichosis with insulin-dependent diabetes mellitus (PHID) syndrome is a rare disease, and part of the cluster histiocytosis-lymphadenopathy plus syndrome (H syndrome), which is associated with mutations in the SLC29A3 gene. Patients with PHID show clinical features of H syndrome but also have insulin-dependent diabetes mellitus. The PHID has previously been described as predominantly in absence of pancreatic autoantibodies. Case Series Presentation: Through an open call in two international diabetes registers, clinical and genetic characteristics of 7 PHID patients in 6 treatment centres were collected after informed consent. All of them had consanguinity in their families, and their origins were located in North-African and Middle Eastern regions. Four out of 7 patients had at least one positive pancreatic autoantibody. DISCUSSION AND CONCLUSION: Our case series reveals that PHID exhibits a wide range of clinical symptoms and signs. When consanguinity is present in a patient with newly diagnosed diabetes, and/or if other atypical symptoms such as dysmorphic features, skin lesions, haematological abnormalities, and developmental delay are present, threshold for genetic analysis should be low. Moreover, the presence of autoantibodies should not withhold genetic testing as our case series contradicts the previous observation of predominant autoantibody absence in PHID.
Centre for Endocrinology Queen Mary University of London London UK
Department for Paediatrics Whipps Cross Hospital Barts Health NHS Trust London UK
Department of Development and Regeneration KU Leuven Leuven Belgium
Department of Paediatric Endocrinology and Diabetes University hospital Leuven Leuven Belgium
Department of Paediatrics Helios Klinikum Krefeld Krefeld Germany
References provided by Crossref.org